<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"><!-- InstanceBegin template="/Templates/xpspurple.dwt" codeOutsideHTMLIsLocked="false" -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<!-- InstanceBeginEditable name="doctitle" -->
<title>XPS Student Tips</title>
<!-- InstanceEndEditable -->
<link href="../styles.css" rel="stylesheet" type="text/css" />
<link href="../stylesb.css" rel="stylesheet" type="text/css" />
<link href="../styles2.css" rel="stylesheet" type="text/css" />
<!-- InstanceBeginEditable name="head" -->
<style type="text/css">
<!--
.style7 {font-size: 12px}
.style8 {
	font-size: medium;
	font-weight: bold;
}
.style11 {	font-size: 11px;
	font-style: italic;
}
-->
</style>
<!-- InstanceEndEditable -->
<style type="text/css">
<!--
.style6 {font-size: 14px}
-->
</style>
</head>
<body>
<div class="wrap">
  <div class="headrow_one">
    <div class="rowone_left">
      <h1><span class="style6">Xeroderma Pigmentosum Society, Inc.</span><br />
	      437 Snydertown Rd.<br />
      Craryville, NY 12521</h1>
      <div class="h1b">
      </div>
    </div>
    <div class="rowone_right"> <br />
      <br />
      <a href="../patmannix.htm">This website is forever dedicated to<br />
      H. Patrick &quot;Pat&quot; Mannix</a><br />
      <br />
    </div>
  </div>
  <div class="headrow_two">
    <div class="rowtwo_left">&nbsp;</div>
    <div class="rowtwo_mid">&nbsp;</div>
    <div class="rowtwo_right">&nbsp;</div>
  </div>
  <div class="mainbody">
    <div class="left">
      <div class="left_content">
        <div class="ntmenu_container">
          <ul id="nav">
            <li><a href="../parents_caregivers.htm" class="toplevel">Parents &amp; Caregivers</a></li>
            <li><a href="../student_tips.htm" class="toplevel">Students/Research</a></li>
            <li><a href="../globalxpappeal.htm" class="toplevel">Global XP Appeal </a></li>
            <li><a href="../research_discovery.htm" class="toplevel">Research &amp; Discovery </a></li>
            <li><a href="../advisoryboard.htm" class="toplevel">Scientific Advisory Board </a></li>
            <li><a href="../campsundown.htm" class="toplevel">Camp Sundown </a></li>
												<li><a href="../campclowns.htm" class="toplevel">Camp Sundown Clowns</a> </li>
            <li><a href="../starsabove.htm" class="toplevel">Stars Above</a> </li>
            <li><a href="../news.htm" class="toplevel">News</a> </li>
            <li><a href="../contactus/index.php" class="toplevel">Contact Us </a> </li>
          </ul>
        </div>
      </div>
    </div>
    <div class="center"><!-- InstanceBeginEditable name="content" -->
      <div class="center_content">
        <h1 class="style2">Students/Research</h1>
        <h2 class="center">To students researching this subject for a school project:</h2>
        <p>XP is categorized in at least eight complementation groups according  to the capacity of the body to repair DNA. These groups (i.e., genetic  subtypes) are labeled A through G, plus the XP variant: XPV. Groups A,  C, D, and Variant make up over 90% of XP cases. Group A, for example,  has the lowest level of DNA repair and the most neurological  manifestations.</p>
       		<h3>Symptoms</h3>
       		<ul>
          <li>Wide range of symptoms
            <ul>
              <li>blistering or freckling on minimum sun exposure</li>
              <li>premature aging of skin, lips, eyes, mouth and tongue; with significant increased incidence of cancer in these same areas</li>
              <li>blindness resulting from eye lesions or surgery for skin cancer close to the eyes</li>
              <li>progressive neurological complications including:
                <ul>
                  <li>developmental disabilities</li>
                  <li>mental retardation</li>
                  <li>high frequency hearing loss, progressing to deafness</li>
                  <li>de Sanctis-Cacchione syndrome (rare)</li>
                </ul>
              </li>
            </ul>
          </li>
          <li>Very rare
            <ul>
              <li>Prevalence  is estimated at 1:1,000,000 in the United States. Certain populations  have a higher prevalence. For example, in Japan, the prevalence is  estimated as 1:40,000. Prevalence is increased in  communities in which  consanguinity is common. (<a href="#xp">reference</a>)</li>
            </ul>
          </li>
          <li>Clinical diagnosis possible</li>
          <li>Life threatening
            <ul>
              <li>The DNA damage is cumulative and irreversible</li>
              <li>Greater than 1000-fold increased risk of skin cancer, or pre-cancerous tumors and mouth and eye tumors</li>
            </ul>
          </li>
          <li>Other disorders associated with defective DNA repair
            <ul>
              <li>Ataxia-Telangiectasia</li>
              <li>Bloom Syndrome</li>
              <li>Cockayne Syndrome</li>
              <li>Fanconi Anemia</li>
              <li>Trichothiodystrophy (TTD)</li>
            </ul>
          </li>
          <li>Other disorders characterized by light sensitivity
            <ul>
              <li>Drug-induced photosensitivity</li>
              <li>Erythropoietic Protoporphyria (EPP)</li>
              <li>Lupus (30% of cases)</li>
              <li>Polymorphous Light Eruption (PLE)</li>
              <li>Porphyria (general)</li>
            </ul>
          </li>
        </ul>
        <p>There is no cure for XP. The DNA damage is cumulative and irreversible. Management is limited to avoidance of exposure to damaging UV radiation by staying indoors with sunlight blocked out, and use of protective clothing, sunscreens and sunglasses. Also, avoid other known carcinogens.</p>
        <p>Regular surveillance for and treatment of all neoplasms is very important.</p>
        <p><a name="xp" id="xp">For the most complete and up-to-date coverage of this disease, please refer to this GeneReviews article:</a><br />
          <a href="http://www.geneclinics.org/query?dz=xp">Xeroderma Pigmentosum</a><br />
          [XP Includes: DeSanctis-Cacchione Syndrome]<br />
          by Daniel J. Wattendorf, MD and Kenneth H. Kraemer, MD.</p>
        <p>Physicians seeking information about xeroderma pigmentosum will find a chapter on the subject written by W Clark Lambert, Claude E Gagna, Santiago A Centurion, Hon Li in the MOSBY book: <em>Treatment of Skin Disease,</em> edited by Mark Lebwohl, Warren Heymann, John Berth-Jones and Ian Coulson. Copywrite 2002.</p>
        <p>XP defined on other Websites (Please use BACK function to return to this site):</p>
        <ul>
          <li><a href="http://directory.google.com/Top/Health/Conditions_and_Diseases/Genetic_Disorders/Xeroderma_Pigmentosum/"> Google Directory</a></li>
          <li><a href="http://www.emedicine.com/DERM/topic462.htm">E-medicine</a></li>
          <li><a href="http://www.emedicine.com/neuro/topic399.htm">Another E-medicine article</a></li>
          <li><a href="http://www.infobiogen.fr/services/chromcancer/Kprones/XerodermaID10004.html">Xeroderma Pigmentosum, Atlas of Genetics and Cytogenetics in Oncology and Haematology</a></li>
        </ul>
        <p>Also, on this site, see:</p>
        <ul>
          <li><a href="parents_caregivers.htm">Tips and information for XP patients and families</a></li>
          <li><a href="http://b.users.bsdwebsolutions.com/%7Expsorg/living_with_XP.htm">Living with XP, CS, and TTD</a><br />
            Some personal accounts provided by patients</li>
          <li><a href="/dnaexplained.htm">An explanation of DNA Repair for patients and          families</a></li>
        </ul>
        <p>Understanding  Ultraviolet (UV) radiation, its effects upon the XP patient, its  measurement, and protection from UV are all extremely important. Please  review these resources:</p>
        <ul>
          <li><a href="/protection.htm">UV protection for persons with xeroderma pigmentosum (XP), An XP Society perspective</a></li>
          <li><a href="/uvnotes.htm#BEYOND">Regarding UV and the XP patient</a></li>
          <li><a href="http://xps.org/uvnotes.htm#PURPLE2">Know your light sources</a></li>
          <li><a href="http://www.inchem.org/documents/ehc/ehc/ehc160.htm">An Authoritative Scientific Review of Environmental and Health Effects of UV</a> (Please use BACK function to return to this site.)</li>
        </ul>
        <p>[To pronounce xeroderma, see <a href="http://www.factmonster.com/ipd/A0742888.html">this        page</a>.]</p>
        <h3>Not sure of diagnosis?</h3>
        <p> Parents of children who seem to have some kind of light or sun  sensitivity may want to consult a dermatologist and discuss the  following with their physicians:<br />
          <a href="http://www.ijdvl.com/article.asp?issn=0378-6323;year=2005;volume=71;issue=2;spage=73;epage=79;aulast=Inamadar">Photosensitivity in children:<br />
          An approach to diagnosis and management</a> </p>
        <h1 class="style2"><span class="style11">The XP Society is the international authority for XP (xeroderma Pigmentosum) family support and information to assist in making intelligent decisions in the caregiving of XP family members. </span></h1>
      </div>
      <!-- InstanceEndEditable --></div>
    <div class="right">
      <div class="featuredservices_container">
        <h4><a href="../howtohelp.htm">How to Help </a></h4>
        <br />
        <div class="featuredservices_nav">
          <ul>
            <li><a href="../howtohelp.htm#donate">Donate</a></li>
            <li><a href="../howtohelp.htm#shop">Shop</a></li>
            <li><a href="../howtohelp.htm#mail">Mail</a></li>
            <li><a href="../howtohelp.htm#fundraiser">Fundraise</a></li>
            <li><a href="../howtohelp.htm#volunteer">Volunteer</a></li>
            <li><a href="../howtohelp.htm#workplacecont">Work Contributions</a></li>
            <li><a href="../howtohelp.htm#estateplaning">Estate Planning</a></li>
          </ul>
        </div>
      </div>
    </div>
  </div>
  <div class="footer_top">
  <div class="basemenu">  <h3>Translation</h3>
    <p>Computer generated translations of this page:<br />
      <a href="http://fets3.freetranslation.com/?Sequence=core&amp;Language=English%2FSpanish&amp;Url=www.xps.org"> Spanish,</a> 
	  <a href="http://fets3.freetranslation.com/?Sequence=core&amp;Language=English%2FFrench&amp;Url=www.xps.org/uvnotes.htm"> French,</a> 
	  <a href="http://fets3.freetranslation.com/?Sequence=core&amp;Language=English%2FGerman&amp;Url=www.xps.org/uvnotes.htm"> German,</a> 
	  <a href="http://fets3.freetranslation.com/?Sequence=core&amp;Language=English%2FItalian&amp;Url=www.xps.org/uvnotes.htm"> Italian,</a> 
	  <a href="http://fets3.freetranslation.com/?Sequence=core&amp;Language=English%2FPortuguese&amp;Url=www.xps.org/uvnotes.htm"> Portuguese,</a> 
	  or 
	  <a href="http://fets3.freetranslation.com/?Sequence=core&amp;Language=English%2FNorwegian&amp;Url=www.xps.org/uvnotes.htm"> Norwegian</a> using <a href="http://www.FreeTranslation.com">FreeTranslation.com</a></p></div>
  <div class="footer_bottom">&copy;
    Copyright  &reg; YourAce&#8482; 2005 | Open Source Design By Mike East For <a href="http://oswd.org" target="_blank">OSWD.ORG</a></div>
</div></div>
</body>
<!-- InstanceEnd --></html>
